![Minji Kim](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Minji Kim
Direttore/Membro del Consiglio presso SK BIOPHARMACEUTICALS CO., LTD.
Provenienza dei contatti di primo grado di Minji Kim
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 11 | |
Public Company | Pharmaceuticals: Major | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Minji Kim tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Sales & Marketing | |
SK TELECOM CO., LTD. | Wireless Telecommunications | Corporate Officer/Principal | |
Oldtech, Inc.
![]() Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Director/Board Member Director of Finance/CFO | |
INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO | |
Autonomic Technologies, Inc.
![]() Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
IPI LEGACY LIQUIDATION CO | Pharmaceuticals: Major | Chief Executive Officer | |
Brickell Subsidiary, Inc.
![]() Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Elicio Therapeutics, Inc. (Old)
![]() Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
University of Pennsylvania | College/University | Doctorate Degree | |
Andera Partners SCA
![]() Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
Kansas State University | College/University | Undergraduate Degree | |
NOXXON Pharma AG
![]() NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
The University of Colorado | College/University | Corporate Officer/Principal | |
Seoul National University | College/University | Corporate Officer/Principal | |
SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member | |
Novartis Institutes for Biomedical Research, Inc.
![]() Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
JenaValve Technology GmbH
![]() JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Medical Specialties | Director/Board Member | |
American Thoracic Society, Inc.
![]() American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Thoracic Society, Inc. is a professional membership organization for thoracic surgeons. The non-profit company is based in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sanifit Therapeutics SA
![]() Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Biotechnology | Director of Finance/CFO | |
ALLERGAN PLC | Pharmaceuticals: Major | Public Communications Contact | |
JenaValve Technology, Inc.
![]() JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Medical Specialties | Director/Board Member | |
Sapiens Steering Brain Stimulation BV
![]() Sapiens Steering Brain Stimulation BV Electronic Equipment/InstrumentsElectronic Technology Sapiens Steering Brain Stimulation BV develops medical devices. The company was founded by Sjaak Deckers in 2011 and is headquartered in Eindhoven, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member | |
SK Planet Co., Ltd.
![]() SK Planet Co., Ltd. Packaged SoftwareTechnology Services SK Planet Co., Ltd. provides e-commerce and digital content platforms and services. It operates through the following business areas: Next Commerce, Digital Platform and Marketing Communication. The Next Commerce business division offers online-to-offline commerce services and online marketplace platforms. The Digital Platform business division encompasses digital content platforms. The Marketing Communication division provides communication planning, promotion, interactive communication and advertising platforms. The company was founded on October 1, 2011 and is headquartered in Seongnam, South Korea. | Packaged Software | Director/Board Member | |
Medlumics SL
![]() Medlumics SL Medical SpecialtiesHealth Technology Medlumics SL provides medical imaging diagnostics services. It specializes in optically guided medical devices. The firm’s proprietary integrated optics platform technology combines optical and electrical components in a miniature chip, enabling for the first time complex multi view optical probes of the size of a grain of rice and ultra-portable, hand-held OCT systems that produces real-time images. The company was founded by Eduardo Margallo Balbás and Jose Luis Rubio Guivernau on April 3, 2009 and is headquartered in Tres Cantos, Spain. | Medical Specialties | Director/Board Member | |
Allecra Therapeutics GmbH
![]() Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Pharmaceuticals: Major | Director/Board Member | |
HighLife SAS
![]() HighLife SAS Medical SpecialtiesHealth Technology HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Institut Für Medizinische Mikrobiologie | College/University | Doctorate Degree | |
TME PHARMA N.V. | Biotechnology | Director/Board Member | |
LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
SK Life Science, Inc.
![]() SK Life Science, Inc. Miscellaneous Commercial ServicesCommercial Services SK Life Science, Inc. operates a pharmaceutical company. The company is headquartered in Paramus, NJ. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Chief Executive Officer | |
COMPASS PATHWAYS PLC | Biotechnology | Director/Board Member | |
Arvelle Therapeutics International GmbH
![]() Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Biotechnology | Director-Back Office Operation Director/Board Member | |
Catalys Pacific LLC
![]() Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Investment Managers | Private Equity Investor | |
FRESH TRACKS THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
T-Knife GmbH
![]() T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
EUCRATES BIOMEDICAL ACQUISITION CORP. | Financial Conglomerates | Founder | |
Flare Therapeutics, Inc.
![]() Flare Therapeutics, Inc. BiotechnologyHealth Technology Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022. | Biotechnology | Director of Finance/CFO | |
Ariceum Therapeutics GmbH
![]() Ariceum Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 25 |
Germania | 9 |
Francia | 6 |
Corea del Sud | 4 |
Svizzera | 4 |
Settori
Health Technology | 33 |
Consumer Services | 6 |
Finance | 5 |
Commercial Services | 5 |
Electronic Technology | 3 |
Posizioni
Director/Board Member | 102 |
Independent Dir/Board Member | 40 |
Corporate Officer/Principal | 37 |
Chief Executive Officer | 13 |
Director of Finance/CFO | 11 |
Contatti più connessi
Insiders | |
---|---|
Srini Akkaraju Akkaraju | 54 |
Olivier Litzka | 21 |
Alexander G. Asam | 18 |
Derek DiRocco | 17 |
Daphne Karydas | 16 |
Glenn Sblendorio | 15 |
Adam Levy | 10 |
David Rodman | 10 |
Jon Congleton | 8 |
BT Slingsby | 8 |
Dong-Hoon Lee | 5 |
Geun-Joo Hwang | 3 |
Jeong-Woo Jo | 3 |
Min-Seop Song | 3 |
Young-Ju Bang | 2 |
- Borsa valori
- Insiders
- Minji Kim
- Connessioni Società